SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-095755
Filing Date
2024-08-13
Accepted
2024-08-13 07:30:20
Documents
63
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vigl-20240630.htm   iXBRL 10-Q 1966135
2 EX-10.1 vigl-ex10_1.htm EX-10.1 37432
3 EX-31.1 vigl-ex31_1.htm EX-31.1 17837
4 EX-31.2 vigl-ex31_2.htm EX-31.2 17791
5 EX-32.1 vigl-ex32_1.htm EX-32.1 10523
6 EX-32.2 vigl-ex32_2.htm EX-32.2 10493
  Complete submission text file 0000950170-24-095755.txt   6890787

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vigl-20240630.xsd EX-101.SCH 988917
65 EXTRACTED XBRL INSTANCE DOCUMENT vigl-20240630_htm.xml XML 986834
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41200 | Film No.: 241198785
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)